Xeris Biopharma Holdings Inc
NASDAQ:XERS
Wall Street
Price Targets
XERS Price Targets Summary
Xeris Biopharma Holdings Inc
According to Wall Street analysts, the average 1-year price target for
XERS
is 11.37 USD
with a low forecast of 8.08 USD and a high forecast of 18.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is XERS's stock price target?
Price Target
11.37
USD
According to Wall Street analysts, the average 1-year price target for
XERS
is 11.37 USD
with a low forecast of 8.08 USD and a high forecast of 18.9 USD.
What is Xeris Biopharma Holdings Inc's Revenue forecast?
Projected CAGR
20%
For the last 8 years the
compound annual growth rate for
Xeris Biopharma Holdings Inc's revenue is
92%.
The projected
CAGR
for the next 3 years is
20%.
What is Xeris Biopharma Holdings Inc's Operating Income forecast?
Projected CAGR
75%
The
compound annual growth rate
of Xeris Biopharma Holdings Inc's operating income for the next 3 years is
75%.
What is Xeris Biopharma Holdings Inc's Net Income forecast?
Projected CAGR
943%
The
compound annual growth rate
of Xeris Biopharma Holdings Inc's net income for the next 2 years is
943%.
